Notice of AGM and 2023 Report and Accounts
Updated : 07:01
Intelligent Ultrasound Group plc
(the "Group" or the "Company")
Notice of Annual General Meeting and
2023 Report and Accounts
Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound company, specialising in artificial intelligence (AI) software and simulation, announces that the following documents have been posted or otherwise been made available to shareholders:
· 2023 Report and Accounts; and
· Notice of 2024 Annual General Meeting ("AGM")
The Notice of AGM and the 2023 Report and Accounts are also available to view on the Company's website at: www.intelligentultrasound.com/reports-presentations
The AGM will be held on Tuesday 18 June 2024 at 10.30 a.m. at Cavendish Capital Markets Limited, One Bartholemew Close, London EC1A 7BL.
Details of how to participate in the Meeting and the resolutions that will be tabled for shareholder approval are set out in the Notice of AGM.
For further information, please contact:
Intelligent Ultrasound Group plc | |
Stuart Gall, CEO | Tel: +44 (0)29 2075 6534 |
Helen Jones, CFO | |
Cavendish Capital Markets Limited (Nominated Advisor and Broker) |
Tel: +44 (0)20 7397 8900 |
Giles Balleny/Dan Hodkinson (Corporate Finance) | |
Nigel Birks (ECM) Ondraya Swanson (ECM) Dale Bellis (Sales)
| |
TB Cardew - PR Advisers Allison Connolly Emma Pascoe-Watson Jessica Pilling | Intelligentultrasound@tbcardew.com Tel: +44 (0)7587 453955 Tel: +44 (0)7774 620415 Tel: +44 (0)7918 584573 |
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:
Simulation
Real-time hi-fidelity ultrasound education and training through simulation. Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator and the BabyWorks Neonate and Paediatric training simulator. To date over 1,700 simulators have been sold to over 800 medical institutions around the world.
Clinical AI software
Deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE HealthCare's SonoLyst software that is incorporated in their Voluson Expert, Signature and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.
NOTE: ScanNav Anatomy PNB is CE approved and cleared for sale in the US by the FDA but is not available for sale in any other territory requiring government approval for this type of product.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.